0000950170-23-051939.txt : 20231004 0000950170-23-051939.hdr.sgml : 20231004 20231004164553 ACCESSION NUMBER: 0000950170-23-051939 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231002 FILED AS OF DATE: 20231004 DATE AS OF CHANGE: 20231004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Werner Jason M. CENTRAL INDEX KEY: 0001977446 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 231308605 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200028718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 ownership.xml 4 X0508 4 2023-10-02 0001267602 ALIMERA SCIENCES INC ALIM 0001977446 Werner Jason M. 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 false true false false Chief Operating Officer false Common Stock 2023-10-02 4 A false 225000 0.00 A 225000 D Stock Option (Right to Buy) 2.99 2023-10-02 4 A false 225000 0 A 2033-10-01 Common Stock 225000 225000 D Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSUs vest in four equal annual installments beginning October 2, 2023, with the first annual installment vesting on October 2, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the grant date through the applicable anniversary thereof. The options shall vest and become exercisable with respect to twenty-five percent (25%) of the shares after twelve (12) months of the Reporting Person's continuous service commencing on October 2, 2023, and the balance will vest in equal monthly installments over the next thirty-six (36) months of the Reporting Person's continuous service with the Issuer thereafter, with the final installment adjusted as necessary to avoid any fractional shares in any installment. /s/ Jason Werner 2023-10-04